ES2129130T3 - Derivados de piperidina y proceso para su produccion. - Google Patents

Derivados de piperidina y proceso para su produccion.

Info

Publication number
ES2129130T3
ES2129130T3 ES94920762T ES94920762T ES2129130T3 ES 2129130 T3 ES2129130 T3 ES 2129130T3 ES 94920762 T ES94920762 T ES 94920762T ES 94920762 T ES94920762 T ES 94920762T ES 2129130 T3 ES2129130 T3 ES 2129130T3
Authority
ES
Spain
Prior art keywords
sub
hydrogen
production
hydroxy
piperidine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94920762T
Other languages
English (en)
Inventor
Ambra Thomas E D
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Curia Global Inc
Original Assignee
Albany Molecular Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22176189&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2129130(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Albany Molecular Research Inc filed Critical Albany Molecular Research Inc
Application granted granted Critical
Publication of ES2129130T3 publication Critical patent/ES2129130T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/86—Unsaturated compounds containing keto groups containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DERIVADOS DE PIPERIDINA SUSTANCIALMENTE PUROS DE FORMULA (I) O (II), DONDE R{SUB,1} ES HIDROGENO O HIDROXI; R{SUB,2} ES HIDROGENO; O R{SUB,1} Y R{SUB,2} JUNTOS FORMAN UNA SEGUNDA UNION ENTRE LOS ATOMOS DE CARBONO QUE PORTAN R{SUB,1} Y R{SUB,2}; R{SUB,3} ES COOH O -COOR{SUB,4}; R{SUB,4} TIENE DE 1 A 6 ATOMOS DE CARBONO; A, B Y D SON LOS SUSTITUYENTES DE SUS ANILLOS CORRESPONDIENTES, PUDIENDO SER CADA UNO DIFERENTE O IGUAL, Y SON HIDROGENO, HALOGENOS, ALQUIL, HIDROXI, ALCOXI, U OTROS SUSTITUYENTES.TAMBIEN SE EXPONE UN PROCESO PARA PREPARAR TALES COMPUESTOS DERIVADOS DE PIPERIDINA EN UNA FORMA SUSTANCIALMENTE PURA.
ES94920762T 1993-06-24 1994-06-21 Derivados de piperidina y proceso para su produccion. Expired - Lifetime ES2129130T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8310293A 1993-06-24 1993-06-24

Publications (1)

Publication Number Publication Date
ES2129130T3 true ES2129130T3 (es) 1999-06-01

Family

ID=22176189

Family Applications (3)

Application Number Title Priority Date Filing Date
ES03077245T Expired - Lifetime ES2261871T3 (es) 1993-06-24 1994-06-21 Procedimiento para preparar compuestos utiles como intermediarios.
ES94920762T Expired - Lifetime ES2129130T3 (es) 1993-06-24 1994-06-21 Derivados de piperidina y proceso para su produccion.
ES00200419T Expired - Lifetime ES2211444T3 (es) 1993-06-24 1994-06-21 Compuestos utiles como productos intermedios en la produccion de derivados de piperidina.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES03077245T Expired - Lifetime ES2261871T3 (es) 1993-06-24 1994-06-21 Procedimiento para preparar compuestos utiles como intermediarios.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES00200419T Expired - Lifetime ES2211444T3 (es) 1993-06-24 1994-06-21 Compuestos utiles como productos intermedios en la produccion de derivados de piperidina.

Country Status (16)

Country Link
US (9) US5750703A (es)
EP (4) EP0703902B1 (es)
JP (4) JP3034047B2 (es)
KR (2) KR100387347B1 (es)
AT (3) ATE322473T1 (es)
AU (1) AU670004B2 (es)
CA (1) CA2147126C (es)
DE (3) DE69433346T2 (es)
DK (3) DK1026147T3 (es)
ES (3) ES2261871T3 (es)
FI (1) FI109691B (es)
HU (1) HU226559B1 (es)
NO (2) NO308599B1 (es)
NZ (1) NZ268513A (es)
PT (2) PT1026147E (es)
WO (1) WO1995000482A1 (es)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE9320925U1 (de) * 1992-08-03 1995-08-31 Georgetown University, Washington, D.C. Terfenadin-Metabolite und deren optisch reine Isomere für die Behandlung von allergischen Störungen
US20020007068A1 (en) 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
EP0703902B1 (en) 1993-06-24 1998-12-16 Albany Molecular Research, Inc. Process for the production of piperidine derivatives
JP3712208B2 (ja) * 1993-06-25 2005-11-02 メレルファーマスーティカルズ インコーポレイテッド 抗ヒスタミン性の４−ジフェニルメチル／ジフェニルメトキシピペリジン誘導体類を製造する新規な中間体
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
CN1148849A (zh) * 1994-05-18 1997-04-30 赫彻斯特马里恩鲁斯公司 抗组胺哌啶衍生物，其多晶形物和假同晶物的无水和水合物形式的制备方法
WO1996026726A1 (en) * 1995-02-28 1996-09-06 Hoechst Marion Roussel, Inc. Pharmaceutical composition for piperidinoalkanol compounds
US6153754A (en) * 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6201124B1 (en) 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US5925761A (en) * 1997-02-04 1999-07-20 Sepracor Inc. Synthesis of terfenadine and derivatives
ZA985939B (en) * 1997-07-08 2000-01-10 Aristocrat Leisure Ind Pty Ltd Slot machine game and system with improved jackpot feature.
CN1159012C (zh) * 1997-08-26 2004-07-28 阿旺蒂斯制药公司 用于组合哌啶子基烷醇-减充血剂的药物组合物
US6194431B1 (en) 1998-04-14 2001-02-27 Paul D. Rubin Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
DK1091938T3 (da) * 1998-07-02 2011-02-07 Aventisub Ii Inc Antihistamin piperidinderivativer og mellemprodukter til fremstilling af disse
US6683094B2 (en) 1998-07-02 2004-01-27 Aventis Pharmaceuticals Inc. Antihistaminic piperidine derivatives and intermediates for the preparation thereof
US6700012B2 (en) 1998-07-02 2004-03-02 Aventis Pharmaceuticals Inc. Antihistaminic piperidine derivatives and intermediates for the preparation thereof
AU2007200674C1 (en) * 1998-07-02 2011-02-24 Aventisub Llc Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
US6362375B1 (en) 1999-12-03 2002-03-26 College Of The Holy Cross Process for the preparation of aryl ketones generating reduced amounts of toxic byproducts
US6613906B1 (en) 2000-06-06 2003-09-02 Geneva Pharmaceuticals, Inc. Crystal modification
GB0018691D0 (en) * 2000-07-28 2000-09-20 Rolabo Sl Process
US6613907B2 (en) 2000-11-08 2003-09-02 Amr Technology, Inc. Process for the production of piperidine derivatives with microorganisms
CZ20033019A3 (cs) * 2001-04-09 2004-07-14 Teva Pharmaceutical Industries Ltd. Polymorfní formy chloridu fexofenadinu
US20030021849A1 (en) * 2001-04-09 2003-01-30 Ben-Zion Dolitzky Polymorphs of fexofenadine hydrochloride
US6743941B2 (en) * 2001-06-15 2004-06-01 Aventis Pharma Deutschland Gmbh Process for the production of piperidine derivatives
JP2004521942A (ja) * 2001-06-25 2004-07-22 オーロビンド ファーマ リミテッド 高純度医薬中間体である４−（シクロプロピルカルボニル）−α，α−ジメチルフェニル酢酸の製造方法
US6593499B2 (en) * 2001-08-29 2003-07-15 Council Of Scientific & Industrial Research Process for the preparation of phenyl ketones
AU2002357701A1 (en) * 2001-11-08 2003-05-19 Teva Pharmaceutical Industries Ltd. Polymorphs of fexofenadine base
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
ES2239554T1 (es) * 2002-06-10 2005-10-01 Teva Pharmaceutical Industries Ltd. Forma xvi polimorfica de hidrocloruro de fexofenadina.
US20050065183A1 (en) * 2003-07-31 2005-03-24 Indranil Nandi Fexofenadine composition and process for preparing
US20050026890A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
GB0319935D0 (en) * 2003-08-26 2003-09-24 Cipla Ltd Polymorphs
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
US20050256163A1 (en) * 2004-04-26 2005-11-17 Ilan Kor Crystalline forms of fexofenadine hydrochloride and processes for their preparation
ITMI20041568A1 (it) * 2004-07-30 2004-10-30 Dipharma Spa "polimorfi di fexofenadina base"
US7498443B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of carebastine
US7498345B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of piperidine derivatives
JP2008514641A (ja) * 2004-09-28 2008-05-08 テバ ファーマシューティカル インダストリーズ リミティド 結晶形フェキソフェナジン、およびその調製方法
US7841939B2 (en) 2005-09-09 2010-11-30 Igt Server based gaming system having multiple progressive awards
US7568973B2 (en) 2005-09-09 2009-08-04 Igt Server based gaming system having multiple progressive awards
WO2007056457A2 (en) 2005-11-09 2007-05-18 Combinatorx, Incorporated Methods, compositions, and kits for the treatment of medical conditions
US7780520B2 (en) 2006-03-15 2010-08-24 Igt Gaming device having multiple different types of progressive awards
WO2007135693A2 (en) * 2006-05-18 2007-11-29 Ind-Swift Laboratories Limited Intermediates useful for the preparation of antihistaminic piperidine derivative
ITMI20061492A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
US8070597B2 (en) 2006-08-03 2011-12-06 Igt Gaming device and method having multiple progressive award levels and a secondary game for advancing through the progressive award levels
US9047733B2 (en) 2006-11-08 2015-06-02 Igt Gaming system and method for providing multiple level progressive awards with increased odds of winning higher level progressive awards
EP2105134A1 (en) 2008-03-24 2009-09-30 Ranbaxy Laboratories Limited Stable amorphous fexofenadine hydrochloride
WO2009136412A2 (en) * 2008-04-25 2009-11-12 Matrix Laboratories Limited PROCESS FOR PREPARATION OF 4-[4-(4-(HYDROXYDIPHENYLMETHYL)- 1-PIPERIDINYL]-1-OXOBUTYL]-α,α-DIMETHYLBENZENE ACETIC ACID METHYL ESTER AND USE THEREOF
LT2278975T (lt) * 2008-05-07 2016-11-25 Cardioxyl Pharmaceuticals Inc. Nauji nitrozo junginiai kaip nitroksilo donorai, ir jų panaudojimo būdas
WO2009158144A1 (en) * 2008-05-30 2009-12-30 Fairfield Clinical Trials Llc Method and composition for dermatoses
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
EP2289867A3 (en) 2009-08-19 2012-04-25 Jubilant Organosys Limited A process for producing 4-(4-halo-1-oxybutyl)-alpha,alpha-dimethylbenzene acetic acid or alkyl esters thereof
US20110130711A1 (en) * 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment
CN102070512B (zh) * 2009-11-21 2014-11-19 浙江华海药业股份有限公司 一种高纯度非索非那定及其中间体的合成路线与制备方法
WO2011063339A1 (en) * 2009-11-23 2011-05-26 Cardioxyl Pharmaceuticals, Inc. Nitroxyl donors for the treatment of pulmonary hypertension
CN102962288A (zh) * 2012-11-21 2013-03-13 苏州江南航天机电工业有限公司 圆弧状大板与直板拼接工艺
ITMI20131652A1 (it) * 2013-10-07 2015-04-08 Dipharma Francis Srl Procedimento per la purificazione di derivati dell'acido 2-fenil-2-metil-propanoico
ES2770341T3 (es) 2015-10-22 2020-07-01 Sanofi Aventis Deutschland Proceso para la preparación de fexofenadina y de productos intermedios usados en ella
CN116178222B (zh) * 2021-11-29 2025-04-25 上海晓明检测技术服务有限公司 环磺酮代谢物m9的制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4028404A (en) * 1967-07-31 1977-06-07 Allen & Hanburys Limited Acetic acid derivatives
GB1242169A (en) * 1969-04-09 1971-08-11 Ucb Sa Piperidine derivatives
US3839431A (en) * 1970-07-13 1974-10-01 Squibb & Sons Inc Cyclopropylmethylphenylacetic acids and derivatives
US3898271A (en) * 1971-06-08 1975-08-05 Squibb & Sons Inc Cyclopropylmethylphenylacetic acids and derivatives
US3806526A (en) * 1972-01-28 1974-04-23 Richardson Merrell Inc 1-aroylalkyl-4-diphenylmethyl piperidines
BE794598A (fr) * 1972-01-28 1973-05-16 Richardson Merrell Inc Nouveaux derives olefiniques de piperidines substituees en 4 et leur procede de preparation
US3965257A (en) * 1972-01-28 1976-06-22 Richardson-Merrell Inc. Compositions and methods for the treatment of the symptoms of histamine induced allergic reactions
BE794596A (fr) * 1972-01-28 1973-05-16 Richardson Merrell Inc Piperidinoalcanone-oximes substituees et leur procede de preparation
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
US3931197A (en) * 1974-02-08 1976-01-06 Richardson-Merrell Inc. Substituted piperidine derivatives
US3941795A (en) * 1974-02-08 1976-03-02 Richardson-Merrell Inc. α-ARYL-4-SUBSTITUTED PIPERIDINOALKANOL DERIVATIVES
US3946022A (en) * 1974-03-04 1976-03-23 Richardson-Merrell Inc. Piperidine derivatives
US3922276A (en) * 1974-12-11 1975-11-25 Robins Co Inc A H 1-Substituted-4-benzylidenepiperidines
US3956296A (en) * 1974-12-11 1976-05-11 A. H. Robins Company, Incorporated 1-Substituted-4-benzylpiperidines
DD141422A5 (de) * 1978-01-27 1980-04-30 Schering Ag Verfahren zur herstellung von phenylessigsaeure-derivaten
US4285958A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkylene ketones, pharmaceutical compositions thereof and method of use thereof
US4285957A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
US4254130A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
GB8321157D0 (en) * 1983-08-05 1983-09-07 Fordonal Sa Piperidine derivatives
IT1200123B (it) 1985-09-27 1989-01-05 Ind Chimica Srl Procedimento per la preparazione di alfa-(p-terbutilfenil)-4-(idrossidifenilmetil)-1-piperidinobutanolo
US4742175A (en) * 1986-05-07 1988-05-03 Merrell Dow Pharmaceuticals Inc. Preparation of polymorphically pure terfenadine
ES2176201T3 (es) * 1992-04-10 2002-12-01 Merrell Pharma Inc Derivados de 4-difenilmetil piperidina y procedimiento de preparacion.
DE9320925U1 (de) * 1992-08-03 1995-08-31 Georgetown University, Washington, D.C. Terfenadin-Metabolite und deren optisch reine Isomere für die Behandlung von allergischen Störungen
US20020007068A1 (en) * 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
EP0703902B1 (en) 1993-06-24 1998-12-16 Albany Molecular Research, Inc. Process for the production of piperidine derivatives
JP3712208B2 (ja) * 1993-06-25 2005-11-02 メレルファーマスーティカルズ インコーポレイテッド 抗ヒスタミン性の４−ジフェニルメチル／ジフェニルメトキシピペリジン誘導体類を製造する新規な中間体
US6147216A (en) 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
AU2001296994A1 (en) * 2000-10-06 2002-04-15 Regents Of The University Of California Nmda receptor channel blocker with neuroprotective activity

Also Published As

Publication number Publication date
US20060052610A1 (en) 2006-03-09
JP3034047B2 (ja) 2000-04-17
US20080227983A1 (en) 2008-09-18
DK1026147T3 (da) 2004-03-22
NO955023D0 (no) 1995-12-12
JP4124998B2 (ja) 2008-07-23
US5589487A (en) 1996-12-31
ATE254594T1 (de) 2003-12-15
HU9503719D0 (en) 1996-02-28
WO1995000482A1 (en) 1995-01-05
KR100387347B1 (ko) 2003-11-28
US7390906B2 (en) 2008-06-24
US5994549A (en) 1999-11-30
EP0703902A1 (en) 1996-04-03
DE69434696T2 (de) 2006-11-16
EP1026147B1 (en) 2003-11-19
JP3195297B2 (ja) 2001-08-06
US20060241303A1 (en) 2006-10-26
EP1369409A1 (en) 2003-12-10
DE69433346D1 (de) 2003-12-24
JP2002212166A (ja) 2002-07-31
CA2147126C (en) 1999-08-24
DE69434696D1 (de) 2006-05-18
US5578610A (en) 1996-11-26
NO955023L (no) 1995-12-12
NO308599B1 (no) 2000-10-02
EP0703902B1 (en) 1998-12-16
ATE174589T1 (de) 1999-01-15
FI956270A0 (fi) 1995-12-27
HU226559B1 (en) 2009-03-30
DE69433346T2 (de) 2004-09-09
US5750703A (en) 1998-05-12
ES2211444T3 (es) 2004-07-16
DK0703902T3 (da) 1999-08-23
ATE322473T1 (de) 2006-04-15
NZ268513A (en) 1996-09-25
EP0703902A4 (es) 1996-04-10
PT1369409E (pt) 2006-08-31
KR100387348B1 (ko) 2003-06-12
AU7174894A (en) 1995-01-17
DK1369409T3 (da) 2006-08-14
FI956270L (fi) 1995-12-27
DE69415319D1 (de) 1999-01-28
US7238834B2 (en) 2007-07-03
PT1026147E (pt) 2004-04-30
ES2261871T3 (es) 2006-11-16
CA2147126A1 (en) 1995-01-05
JP2001031650A (ja) 2001-02-06
JPH11236373A (ja) 1999-08-31
NO994582D0 (no) 1999-09-21
EP0723958A1 (en) 1996-07-31
FI109691B (fi) 2002-09-30
HUT73235A (en) 1996-07-29
JPH08511806A (ja) 1996-12-10
DE69415319T2 (de) 1999-06-10
AU670004B2 (en) 1996-06-27
EP1026147A1 (en) 2000-08-09
US5663412A (en) 1997-09-02
US5581011A (en) 1996-12-03
JP3658291B2 (ja) 2005-06-08
KR960703398A (ko) 1996-08-17
EP1369409B1 (en) 2006-04-05
NO994582L (no) 1995-12-12

Similar Documents

Publication Publication Date Title
ES2129130T3 (es) Derivados de piperidina y proceso para su produccion.
ES2083569T3 (es) Nuevos derivados de ariletenileno y procedimiento para su preparacion.
AR048073A2 (es) 40-o-(2-hidroxi-etil)-rapamicina, proceso para su produccion y composicion farmaceutica que la contiene
MY100740A (en) Spiro-substituted glutaramide diuretic agents.
ES2062395T3 (es) Nuevos compuestos de bencimidazol y su uso.
ES464136A1 (es) Procedimiento para la preparacion de derivados de quinazolo-na.
AU7335896A (en) Phenylethanolamine compounds useful as beta3 agonist, process for producing the same, and intermediates in the production of the same
ATE42303T1 (de) Herstellung von nukleosiden.
ATE126261T1 (de) Verfahren zur trocknung von kohle für einschmelz- bzw. kohlevergaser.
ATE356815T1 (de) Herstellung von perylen-3,4-dicarbonsäure- anhydriden
ATE75470T1 (de) Tricyclische 5,6,7,8-tetrahydro-naphtho (2,3b>2,3-dihydrofuran- und 6,7,8,9-tetrahydro-5hbenzocyclohepta (2,3b>-2,3dihydrofuranaminderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ES2098403T3 (es) Derivados de la imidazoindolizina y procedimiento para su preparacion.
ZA838074B (en) Indole derivatives,process for producing them and their use as intermediates
ES8703424A1 (es) Procedimiento para la obtencion de compuestos de amida
ES485733A1 (es) Procedimiento para la obtencion de derivados de esteres de 1,1,2-trifenilalqueno
CO4410199A1 (es) Procedimiento estereoselectivo para producir derivados de dihidro-2,3-benzodiacepina
CO5170499A1 (es) 1,2,3,4,5, 6-hexahidro-2,6-metano-3-benzazocin-10-oles sustituidos con n-(5-fenil-tetrahidrofuranil)metilo y n-(6-fenil-tetrahidropiranil)metilo; procedimientos para prepararlos y su empleo como composiciones farmaceuticas
GR1000423B (el) Μεθοδος παρασκευης παραγωγων φαινυλοσουλφονης.
MX9303640A (es) Proceso mejorado para la produccion de anhidrido ftalico.
MX9306388A (es) Procedimiento y compuestos intermedios para la obtencion de 2-fenil-5-(3-fenoxifenil)-1,1,1-trifluoropentanos
AR248272A1 (es) Procedimientos para obtener derivados racemicos u opticamente activos de la isoquinolina.
ES2038616T3 (es) Un procedimiento para preparar 2,3-dihidro-1-(8-metil-1,2,4-triazolo(4,3-b)piridazin-6-il)-4-(1h)-piridinona.
ES8601948A1 (es) Un metodo para preparar compuestos de fenilpiperazina sustituida.
KR850008163A (ko) 2,4-디아미노-6-할로게노-5-알킬티오-피리미딘의 제조방법
ES2111309T3 (es) Enantiomeros farmacologicamente activos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 703902

Country of ref document: ES